New Cold-Adapted Donor Strains for Live Influenza Vaccine


Cite item

Full Text

Abstract

Cold-adapted (CA) strains A/Krasnodar/35 and B/Victoria/63 were isolated using passages of A/Krasnodar/101/59 and B/Victoria/2/87 wild type strains at low temperatures. The resulting CA strains possessed TS and CA phenotypes and had a reduced ability to reproduce in mouse lungs and nasal turbinates. They displayed a high protective efficacy in experiments on mice. The two CA strains reproduced well in chick embryos and MDCK cell line without change of TS and CA markers. The CA A/Krasnodar/35 strain during passages at low temperature acquired 13 mutations in the 6 internal genes, 8 of those mutations led to amino acid changes. The CA B/Victoria/63 strain acquired 8 mutations in the internal genes, 6 of which led to amino acid changes. The intranasal vaccination of mice with the CA A/Krasnodar/35 strain led to a transitory suppression of various lymphocyte subpopulations, as well as to an increase in the number of some other cell types. The CA strains in question may be used in the future as attenuation donors for live influenza vaccines.

Full Text

Новые холодоадаптированные штаммы-доноры аттенуации для живых вакцин против гриппа
×

References

  1. Александрова Г. И., Климов А. И. Живая вакцина против гриппа. СПб., 1994.
  2. Ахматова Н. К., Егорова Н. Б., Курбатова Е. А. и др. Влияние хитозана на иммунофенотип и функциональную активность мононуклеарных лейкоцитов мышей при иммунизации инактивированной противогриппозной вакциной. Журнал микробиологии, эпидемиологии и иммунобиологии. 2008; 6: 31—35.
  3. Гендон Ю. З. Живая холодоадаптированная гриппозная вакцина: современное состояние. Вопросы вирусологии. 2011; 1: 4—17.
  4. Киселева И. В., Климов А. И., Григорьева Е. П. и др. Генетический и фенотипический анализ гетерогенной популяции холодоадаптированного донора аттенуации А/Ленинград/134/17/57 (H2N2) и реассортантных гриппозных вакцинных штаммов, подготовленных на его основе. Вопросы вирусологии. 2005; 5: 14—18.
  5. Рекстин А. Р., Найхин А. Н., Баранцева И. Б. и др. В-клеточный цитотоксический лимфоцитарный иммунный ответ на патогенные, аттенуированные и реассортантные вирусы гриппа. Вопросы вирусологии. 2002; 4: 27—32.
  6. Рекстин А. Р., Лу К., Кац Д. и др. Особенности продукции ранних цитокинов in vivo после инфицирования вирусом гриппа А/Ленинград/134/57 (H2N2) и его холодоадаптированными аттенуированными вариантами. Вопросы вирусологии. 2006; 2: 27—31.
  7. Chan W., Zhou H., Kemble G. et al. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, master donor virus for olive attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature. Virology. 2008; 380: 304—311.
  8. Chen Z., Aspelund A., Kemble G. et al. Genetic mapping of the cold-adapted phenotype of B/Ann/ Arbor/I/66, the master donor virus for live attenuated vaccine (FluMist). Virology. 2006; 345: 416—423.
  9. Chen Z., Aspelund A., Kemble G. et al. Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/I/66, the master donor virus for live attenuated influenza Flu Mist vaccines. Virology. 2008; 380: 354—362.
  10. Cox N., Kitame F., Kendal A. et al. Identification of sequence change in the cold-adapted, live attenuated influenza vaccine strain A/Ann Arbor/6/60 (H2N2). Virology. 1988; 167: 554—567.
  11. Ennis F., Rook A., Qi Y. et al. HLA restricted virus-specific cytotoxic T-lymhocyte responses to live and inactivated influenza vaccines. Lancet. 1981; 2: 887—891.
  12. Donabedian A., DeBorde D., Cook S. et al. A mutation in the PA protein gene of cold-adapted B/Ann Arbor/1/66 influenza virus associates with reversion of temperature sensitivity and attenuated virulence. Virology. 1988; 163: 444—451.
  13. Ghendon Y., Klimov A., Alexandrova G. et al. Analysis of genom composition and rectogenicity of recombinants of cold-adapted and virulent strains. J. Gen.Virol. 1981; 53: 215—224.
  14. Ghendon Y., Polezhaev F., Lisovskaja A. et al. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect. and Immun. 1984; 44: 730—733.
  15. Ghendon Y., Markushin S., Vasiliev Y. et al. Evaluation of properties of chitozan as an adjuvant for inactivated influenza vaccines administrated parenterally. J. Med. Virol. 2009; 81: 494—506.
  16. Herlocher M., Clavo A., Maassab H. Sequence comparisons of A AA/6/60 influenza viruses: mutations which may contribute to attenuation. Virus Res. 1996; 42: 11—25.
  17. Hoffmann E., Mahmood K., Chen Z. et al. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J. Virol. 2005; 79: 11014—11021.
  18. Jin H., Lu B., Zhou H. et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strain (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology. 2003; 306: 18—24.
  19. Jin H., Zhou H., Lu B. et al. Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. J. Virol. 2004; 78: 995—998.
  20. Kiseleva I., Klimov A., Su Q. et al. Role of individual genes of the A/Leningrad/134/17/57 (H2N2) cold-adapted donor strain in manifestation of the temperature-sensitive phenotype of reassortant influenza A viruses. Int. Congress. Series. 2004; 1263: 547—550.
  21. Kiseleva I., Voeten T., Teley L. et al. PB2 and PA genes control the expression of the temperature sensitive phenotype of cold-adapted B/USSR/6/60 influenza master donor virus. J. Gen. Virol. 2009. do.10.1099/vir.0.01799-0.
  22. Klimov A., Cox N., Yotov W. et al. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology. 1992; 186: 795—797.
  23. Lee K., Seo S., Song J. et al. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Vaccine. 2006; 24: 1966—1974.
  24. Maassab H. Adaptation and growth characteristics of influenza virus at 25 degrees C Nature. 1967; 213: 612—614.
  25. Maassab H. Biologic and immunologic characteristics of cold-adapted influenza viruses. J. Immunol. 1969; 102: 728—732.
  26. Maassab H., DeBorde D. Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine. 1985; 3: 355—369.
  27. Nichol K., Mendelman P., Mallon K. et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. J. A. M. A. 1999; 282: 137— 144.
  28. Nobusava E., Sato K. Comparison of mutation rates of human influenza A and B viruses. J. Virol. 2006; 80: 3675—3678.
  29. Rudenko L., Arden N., Grigorieva E. et al. Safety and immunogenisity of Russian live attenuated and USA inactivated influenza vaccines in elderly. In: Option of the control of influenza III. Elsevier Science. 1996; 572—578.
  30. Seo S., Byun Y., Lee E. et al. Development and characterization of live attenuated influenza B virus vaccine candidate. Vaccine. 2008; 26: 874—881.
  31. Snyder M., Betts R., De Borde D. et al. Four viral genes independently contributed to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccine. J. Virol. 1988; 62: 488—495.
  32. Stevenson P., Doherty P. Cell-mediated immunoresponse to influenza. In: Nikolson K. et al., eds. Textbook of influenza. Blackwell Science. 1998; 278—287.
  33. Treanor J., Perkins M., Battaglia R. et al. Evaluation of the genetic stability of the temperature-sensitivity PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus. J. Virol. 1994; 68: 7684—7686.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Ghendon Y.Z., Markushin S.G., Tsfasman T.M., Akopova I.I., Ahmatova N.K., Koptiaeva I.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies